Ferroptosis is triggered by lipid peroxidation and is tightly regulated by SLC7A11, a key component of the cystine-glutamate antiporter [42], and thus, exploring its regulatory mechanism is helpful in finding further novel therapeutic targets for inducing ferroptosis in cancer therapy. The gene discussed is SLC7A11; the disease is cancer.